Drexel University College of Medicine

- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1848-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.drexelmed.edu
Clinical Trials
28
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing
- First Posted Date
- 2017-04-17
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Drexel University College of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT03117166
- Locations
- 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- Interventions
- Radiation: RadiotherapyBiological: CetuximabDrug: Erythropoetin
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Drexel University College of Medicine
- Target Recruit Count
- 1
- Registration Number
- NCT01467115
- Locations
- 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias
- Conditions
- Cardiac Arrhythmia
- First Posted Date
- 2011-05-25
- Last Posted Date
- 2013-06-14
- Lead Sponsor
- Drexel University College of Medicine
- Registration Number
- NCT01359683
- Locations
- 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- Drexel University College of Medicine
- Target Recruit Count
- 24
- Registration Number
- NCT01318408
- Locations
- 🇺🇸
Drexel University College of Medicine, Dept of Neurology, Philadelphia, Pennsylvania, United States
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
- First Posted Date
- 2009-06-26
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Drexel University College of Medicine
- Target Recruit Count
- 5
- Registration Number
- NCT00928811
- Locations
- 🇺🇸
Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next